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OVERVIEW OF LYMPHOHAEMATOPOIETIC
MALIGNANCIES
Leukaemia
The major types of leukaemias included in this burden estimation
are acute myeloid leukaemia (AML), chronic lymphoid leukaemia
(CLL), chronic myeloid leukaemia (CML) and acute lymphoid (ALL)
leukaemia. It should be noted that, in the more recent WHO
classification of haematopoietic malignancies, both ALL and CLL are
classified within non-Hodgkin’s lymphomas (NHLs) and in parti-
cular in B-cell neoplasms (Jaffe et al, 2001). In 2004, the UK age-
standardised incidence rates for leukaemia overall for men and
women were 13.5 and 9.5 per 100,000, respectively, and have
fluctuated around these levels since the 1970s (Swerdlow et al, 2001).
One-year relative survival from all leukaemias was around 60%, and
5-year survival was around 38% for patients diagnosed between 1996
and 1999 in England and Wales. Survival from leukaemia has
steadily increased since the 1980s, and more so in men, but rates
differ between the subtypes of leukaemia (Rachet et al,2 0 0 8 c ) .N o n -
occupational causes of leukaemia are viruses (e.g., Epstein–Barr
virus; Dalgleish, 1991) and smoking, which has been particularly
associated with acute leukaemias (Linet et al, 2006).
Multiple myeloma
Multiple myeloma (MM) is a disease of the elderly, being virtually
unknown in childhood and very uncommon in young adults (LRF,
2006a); it develops from antibody-secreting plasma cells in the
bone marrow. Between 1995 and 2005, there was an average of over
3500 new registrations each year in England, Wales and Scotland,
and an average of 3180 deaths (HSE, 2012b), with the temporal
pattern for mortality being similar to that of incidence (Swerdlow
et al, 2001). The 5-year relative survival rate for MM has signi-
ficantly improved between 1986–1990 and 1996–1999 (Rachet
et al, 2008a), but with little improvement in 10-year survival rates.
Obesity (Alexander et al, 2007) and dietary intake of meats and fats
have been suggested as risk factors for MM, as have prior medical
conditions or treatments (de Roos et al, 2006).
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma is a mixture of different pathologies of
varying aetiology (Zinzani, 2005), most arising in the central
lymph nodes (70–80%) and the remaining in the extra-nodal
tissue (Grulich and Vajdic, 2005). In the United Kingdom, there
are over 8500 new registrations of NHL annually (Cartwright et al,
2005; LRF, 2006b). The number of deaths from NHL in Great
Britain has been consistently around 4400 per year over the past 7
years. Trends in mortality approximately follow those in incidence,
with rates significantly increasing in older age groups (Swerdlow
et al, 2001). In Britain, the age-standardised incidence rate
increased by 6% between 1995 and 2004 (ONS, 2006). The 5-year
relative survival rate for NHL in England and Wales was around
46% for patients diagnosed in the late 1980s (Rachet et al, 2008b),
and has improved by about 4% every 5 years since. Certain viral
infections, including the Epstein-Barr virus and HIV (AIDS) virus,
are known risk factors for NHL (Grulich and Vajdic, 2005), and
Helicobacter pylori infection is strongly associated with MALT
lymphoma of the stomach (Farinha and Gascoyne, 2005). Obesity
is associated with an increased risk of NHL (Larsson and Wolk,
2007), and a correlation between the incidence of NHL and
ambient solar ultraviolet radiation has been suggested (McMichael
and Giles, 1996). Non-ionising radiation (IR; e.g., from mobile
phones) may increase the risk of developing NHL (Karipidis et al,
2007).
METHODS
Occupational risk factors
Group 1 and 2A human carcinogens The agents that the
International Agency for Research on Cancer (IARC) has classified
as either definite (Group 1) or probable (Group 2A) human
carcinogens for leukaemia, MM and NHL are summarised in
Table 1. Other occupational circumstances classified by IARC
*Correspondence: Dr L Rushton; E-mail: l.rushton@imperial.ac.uk
See Appendix for the members of the British Occupational Cancer
Burden, Study Group.
British Journal of Cancer (2012) 107, S41–S48
& 2012 Cancer Research UK All rights reserved 0007– 0920/12
www.bjcancer.comas definite carcinogens for leukaemia that have been consi-
dered within the estimate for benzene are boot and shoe
manufacture and repair, petroleum refining and work in the
rubber industry.
Choice of studies providing risk estimates for
leukaemia, MM and NHL
A detailed review of occupational risk factor studies for leukaemia,
MM and NHL is provided in the relevant Health and Safety
Executive (HSE) technical reports (HSE, 2012a,b,c).
Occupational exposures common to leukaemia, MM and
NHL
Non-arsenical insecticides A large number of epidemiological
studies have examined cancer risk among farmers and other
agricultural workers exposed to non-arsenical insecticides or
pesticides in general. These found increased risks for leukaemia
(including specific sub-types), MM and NHL (Descatha et al, 2005;
de Roos et al, 2006; Linet et al, 2006; Alexander et al,2 0 0 7 ) .T h eU S
Agricultural Health Study, a large study of pesticide users, has
observed excesses in mortality and incidence (Alavanja et al, 2005;
Blair et al, 2005), but some of the exposure circumstances are not
observed in GB. For the present study, risk estimates were obtained
for the following groups of workers and are summarised in Table 2.
Farmers and agricultural workers Two large meta-analyses of
farmers exposed to non-arsenical insecticides were undertaken by
Khuder et al (1998) and Acquavella et al (1998), the former
including 33 studies and the latter 28 studies; only 16 studies were
included in both meta-analyses. The risk estimates of Acquavella
et al (1998) were used for the present study because the overall
relative risks (RRs) were in agreement with a previous analysis by
Blair et al (1992) and were more applicable to farmers and other
workers in GB.
Manufacture of pesticides A meta-analysis by Jones et al (2009)
that included studies from around the world of crop protection
product manufacturing workers was used, and the risk estimate
for this group was applied to workers employed in pesticide
manufacturing.
Table 1 Occupational agents, groups of agents, mixtures and exposure circumstances classified by the IARC Monographs, Vols 1–77 (IARC,
1972–2001), into Groups 1 and 2A, which targets the lymphohaematopoietic system and for which burden has been estimated
Agents, mixture, circumstance Main industry, use Evidence of
carcinogenicity
in humans
Source of data for
estimation of numbers
ever exposed over
REP
Comments
Group 1: Carcinogenic to humans
Agents, groups of agents
Benzene Production; boot and shoe industry;
chemical, pharmaceutical and rubber
industries; printing; petrol additive
Leukaemia sufficient CAREX Estimated for acute lymphocytic
and acute monocytic leukaemia
Ionising radiation Radiologists, technologists, nuclear workers;
aircraft crews; underground miners
Leukaemia sufficient CIDI
LFS
British Airways Stewards and
Stewardesses Association
Excluding CLL
Ethylene oxide Production; chemical industry; sterilising
agent (hospitals, spice fumigation)
Leukaemia sufficient CAREX
Formaldehyde Production; pathologists; medical laboratory
technicians; plastics, textile and plywood
industries
Leukaemia sufficient CAREX
TCDD Production; use of chlorophenols and
chlorophenoxy herbicides; waste
incineration; PCB production; pulp
and paper bleaching
NHL limited LFS
Group 2A: Probably carcinogenic to humans
Agents, groups of agents
Non-arsenical insecticides Production; pest control and agricultural
workers; flour and grain mill workers
Leukaemia limited
NHL limited
Multiple myeloma
limited
LFS
1,3-Butadiene Chemical and rubber industries Leukaemia limited CAREX
Tetrachloroethylene Production; dry cleaning; metal degreasing NHL limited CAREX
Trichloroethylene Production; dry cleaning; metal degreasing NHL limited CAREX
Exposure circumstances
Hairdressers and barbers Dyes (aromatic amines, amino-phenols
with hydrogen peroxide); solvents;
propellants; aerosols
NHL limited LFS
Abbreviations: CAREX¼CARcinogen EXposure database; CIDI¼central index of dose information; CLL¼chronic lymphoid leukaemia; IARC¼International Agency for
Research on Cancer; LFS¼Labour Force Survey; PCB¼polychlorinated biphenyl; REP¼risk exposure period; TCDD¼2,3,7,8-tetrachlorodibenzo-para-dioxin.
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(1990) of US Grain Millers using pesticides to control insect
infestation was used.
Occupational exposures considered for NHL
TCDD Dioxins or chlorinated dibenzo-p-dioxins are structurally
similar to chlorinated hydrocarbons (the most toxic form being
dioxins), and are by-products of industrial processes (e.g., coke
production, manufacture of non-ferrous metals, lime; Eduljee and
Dyke, 1996) and combustion (e.g., burning biomass, coal, oil), and
may be released at metal and waste recycling sites (Sweetman et al,
2004). For TCDD, the following risk estimates were used for
specific occupational groups:
Risk estimates for occupational exposure to TCDD and NHL
Agriculture/horticulture workers: an estimate for NHL was not
carried out because non-arsenical insecticides were considered to
be the dominant exposure.
Manufacture of pesticides: an overall risk estimate from the
meta-analysis by Jones et al (2009) (SMR¼1.98, 95% CI¼
1.45–2.69) was used because the number of workers specifically
involved in the manufacture of phenoxy herbicide pesticides in GB
could not be identified.
Pulp manufacture: the risk estimate (SMR¼0.86, 95%
CI¼0.64–1.13) was chosen from an international collaborative
study (McLean et al, 2006), which included a study from Scotland
(Coggon et al, 1997).
Other industries: an SMR of 1.4 (95% CI¼0.6–2.7) from a
study by Bodner et al (2003) was chosen, which reported eight
NHL deaths among a cohort of workers involved in chemical
production.
Risk estimates for employment as hairdressers and barbers and NHL
An increased risk of NHL has been associated with work as a
hairdresser, barber or beautician (Teta et al, 1984; Boffetta et al,
1994; Lamba et al, 2001). For the present study, a standardised
incidence ratio (SIR) of 1.20 (95% CI¼0.84–1.66) was chosen
from the study by Boffetta et al (1994), which covered four
European countries (Denmark, Sweden, Norway and Finland)
and was adjusted for age. The studies by Teta et al (1984) and
Lamba et al (2001) were excluded as they were conducted outside
Europe.
Tetrachloroethylene (perchloroethylene) Tetrachloroethylene (PERC)
is widely used for dry cleaning fabrics, metal degreasing in the
automotive and metalworking industries and in consumer
products, e.g., paint strippers, printing inks (IARC, 1995; ATSDR,
1997a). This chemical has consistently been associated with an
increased risk of NHL (Fritschi et al, 2005).
Risk estimates for occupational exposure to PERC and NHL For
the present study, a US study by Ruder et al (2001) was chosen to
obtain a risk estimate of 1.39 (95% CI¼0.56–2.86), because it
involved a large number of dry cleaning and laundry workers with
an extended follow-up and good exposure assessment; individuals
‘ever exposed’ to carbon tetrachloride (the primary solvent used in
dry cleaning until the 1950s) were excluded. This risk estimate was
used for all workers (not just dry cleaners) with high exposure to
PERC. Because of the absence of sufficient dose–response data for
low exposure, the risk estimate was based on a harmonic mean of
the high/low ratios across all other cancer–exposure pairs in the
overall project where data were available. As this was o1, the
RR for low exposure has been set to 1.
Trichloroethylene Trichloroethylene (TCE) is a chlorinated
hydrocarbon commonly used as an industrial solvent for vapour
or cold degreasing operations: furniture and fixtures, fabricated
metal products, electrical equipment and transport equipment
(IARC, 1995). It has also been used as a chemical intermediate and
component in adhesives, lubricants, paints, varnishes, paint
strippers and pesticides (ATSDR, 1997b).
Risk estimates for occupational exposure to TCE and NHL For
TCE, the summary risk estimate of 1.29 (95% CI¼1.00–1.66) from
the study by Mandel et al (2006) was used, as this meta-analysis
included recent published studies not considered in previous
quantitative and qualitative reviews. Because of the absence of
sufficient dose–response data, the risk estimate for low
exposure was based on a harmonic mean of the high/low ratios
across all other cancer–exposure pairs in the overall project where
data were available. As this was o1, the RR for low exposure has
been set to 1.
Other occupational exposures considered for leukaemia
Benzene Benzene is a by-product of coke production, a
constituent of petrol, and is used extensively in the chemical
industry, and previously in shoe and boot manufacturing.
Exposure to benzene among motor mechanics and aviation
workers has been shown to be high (Capleton and Levy, 2005).
There is a complex relationship between exposure to benzene and
the risk of developing different types of leukaemia, which is
summarised in the HSE technical report (HSE, 2012a) and by
Schnatter et al (2005). For some types of leukaemia (e.g., AML),
the relationship is considered by some researchers to be strong,
but for other types such as CLL it is regarded as equivocal. Risk
estimates for total leukaemia for the populations studied vary
widely from below 1 to about 7 (Savitz and Andrews, 1997). The
following risk estimates were selected and used for acute non-
lymphocytic leukaemia (ANNL).
Work in industrial chemical manufacturing: the RR of 2.17 (95%
CI¼0.9–5.2) from a mortality study of Collins et al (2003) of men
and women in a US chemical plant exposed to benzene.
Distribution and land transport: the RR estimate of 1.32 (95%
CI¼0.49–2.88) for acute non-lymphocytic leukaemia (ANLL)
from a cohort mortality study of a large Canadian petroleum
company (Lewis et al, 2000).
Other exposures considered low: for those industry groups where
benzene exposure occurred at low levels, i.e., likely to be below
1p.p.m., including refinery and oil distribution workers (Runion,
1988; Schnatter et al, 2005), an overall RR of 1.11 (95% CI¼
0.3–2.83) was selected from a study by Bloemen et al (2004).
1,3-Butadiene 1,3-butadiene is used in the production of
synthetic rubbers, synthetic elastomers, carpets, paper coatings,
paints and vehicle parts.
Risk estimates for occupational exposure to 1,3-butadiene and
leukaemia The highest risk estimate (adjusted for exposure to
styrene and dimethyldithiocarbamate) of 2.30 (95% CI¼0.6–8.3)
Table 2 Summary of risk estimates used for different groups and
malignancies related to exposure to non-arsenical pesticides
Farmers and
other workers
Crop
protection
manufacturers
Flour and
grain industry
Leukaemia 1.10 (1.02–1.18) 1.08 (0.81–1.44) 1.07 (0.75–1.47)
NHL 1.03 (0.96–1.12) 1.98 (1.45–2.69) 1.00 (0.64–1.48)
Myeloma 1.09 (0.99–1.19) 1.26 (0.89–1.77) 1.01 (0.50–1.81)
Abbreviation: HHL¼Non-Hodgkin’s lymphoma.
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United States and Canada (Delzell et al, 2001) was selected for the
highly exposed workers based on a precautionary approach. A risk
estimate of 1.30 (95% CI¼0.4–4.3) from the same study was
selected for low-exposure groups. All of the exposed workers were
assumed to be men. This cohort has consistently been shown to be
at an increased risk (Sathiakumar et al, 1998; Delzell et al, 2001),
and the most recent assessment of this cohort gave an SMR of 1.41
(95% CI¼1.05–1.86); however, no relationship with duration of
employment was reported, and all the leukaemia deaths occurred
in men first employed before 1950.
Ethylene oxide/ethylene dioxide Ethylene oxide (EO) is used
widely as a sterilising agent, disinfectant, pesticide, and as an
intermediary in the synthesis of ethylene glycol (anti-freeze) and
other products. Exposure occurs in hospitals, as well as in
chemical and pharmaceutical manufacture.
Risk estimates for occupational exposure to EO/ethylene dioxide
and leukaemia For the present study, risk estimates for high
exposure groups were selected from a study of workers exposed to
EO in Britain (Coggon et al, 2004), and in which the leukaemia
deaths occurred in a subset of subjects with the greatest potential
for exposure to EO: a risk estimate of 1.08 (95% CI¼0.03–6.02)
was obtained for high exposure among medical workers (males
and females); and an estimate of 2.29 (95% CI¼0.62–5.86) was
obtained for high exposure in chemical manufacture. For the low-
exposure groups (male and female), a RR of 1.0 was assigned based
on the meta-SMR of 0.95 (95% CI¼0.64–1.35) in Teta et al (1999).
In general, studies of EO exposure and leukaemia have been of
varying size and quality.
Formaldehyde Formaldehyde is used mainly in the production of
phenolics, urea, melamine and polyacetal resins, and as an
intermediary in industrial chemical manufacture. These have wide
uses as adhesives and binders for wood products, pulp and paper
manufacture, in synthetic vitreous fibre industries, for the
production of plastics and coatings and in textile finishing. High
formaldehyde exposure occupations include textile operations and
wood product manufacture/processing (with coexposure to wood
dust); short-term high-exposure episodes have been reported for
embalmers, pathologists and paper industry workers.
Risk estimates for occupational exposure to formaldehyde and
leukaemia For the present study, risk estimates were chosen
from a meta-analysis of 18 epidemiological studies of workers
exposed to formaldehyde (Collins and Lineker, 2004). For embal-
mers, a meta-RR (mRR)¼1.6 (95% CI¼1.2–2.0) for leukaemia, was
used for health and veterinary service employees, as well as for
research scientists. For pathologists and anatomists, an mRR of 1.4
(95% CI¼1.0–1.9) from this same study was chosen. For those
industrial workers reported to have high cumulative exposures to
formaldehyde, an mRR of 1.2 (95% CI¼0.8–1.8) was taken from the
study by Collins and Lineker (2004). For the low ‘background’
exposure groups (men and women), the risk estimate was assigned
an RR of 1.0. Other studies of industrial workers exposed to
formaldehyde report a positive association between exposure and
leukaemia risk (Hauptmann et al, 2003; Pinkerton et al, 2004),
whereas one British study did not find any positive association even
for those exposed at high levels for long periods (Coggon et al, 2003).
Ionising radiation Ionising radiation is an established cause of
leukaemia, although it appears to have no effect on the risk of CLL
(Higginson et al, 1992).
Risk estimates for occupational exposure to IR and leukaemia For
the present study, the RRs for occupational exposure to IR were
obtained from UNSCEAR (2008), using models of excess RR
(HSE, 2012a) with an RR estimate of 1.027 (for an estimated
average lifetime dose of 11.5mSv) and a separate RR estimate of
1.036 for male and female aircrew (with an estimated average
lifetime dose of 15.3mSv).
A large number of studies with varying risk estimates have been
carried out of workers (in nuclear power stations and defence work
and workers included in the National Registry for Radiation
Workers) in the United Kingdom exposed to IR. A meta-analysis
of UK and US studies showed a significantly increased RR for
leukaemia of 1.8 for workers who received a cumulative dose of
10–50mSv (Wilkinson and Dreyer, 1991). For European airline
pilots and flight engineers exposed to IR of cosmic origin, a range
of risk factors from 0.51 to 1.39 have been reported for all
leukaemias and sub-types (Irvine and Davies, 1999; Blettner et al,
2003; Langner et al, 2004). A combined study of UK, Canadian and
US cohorts found a mortality risk for all leukaemias (excluding
CLL) with an excess RR of 2.18 per Sv (95% CI¼0.1–5.7) (Cardis
et al, 1995). An update including a further 12 countries found
similar results (Cardis et al, 2005).
Estimation of numbers ever exposed
The data sources, major industry sectors and jobs for estimation
of numbers ever exposed over the risk exposure period (REP)
defined as the period during which exposure occurred that was
relevant to the development of the cancer in the target year 2005,
are given in Table 1.
Three sources of data were used to obtain numbers exposed
above 0.1mSv IR in Britain: numbers exposed in 1995 above
0.1mSv from the HSE’s Central Index of Dose Information in
various industries (HSE, 1998); the 1991 Labour Force Survey for
aircraft flight deck officers and male travel and flight attendants;
information from the British Airways Stewards and Stewardesses
Union for female air stewardesses.
High exposures to formaldehyde were assumed for textile and
glass manufacture, education, research, health, and household and
personal services. The industrial processes operating in the United
Kingdom listed by Eduljee and Dyke (1996) were used as the basis
for identifying the relevant occupational groups exposed to TCDD.
High exposure to 1,3-butadiene was assumed for the manufacture of
rubber. Workers involved in the manufacture of machinery, personal
and household services and manufacture of fabricated metal
products were classified as high exposure to tetrachloroethylene.
High exposures to TCE were assumed for manufacture of clothes,
manufacture of fabricated metal products, machinery and transport
equipment, as well as personal and household services.
RESULTS
Because of assumptions made about cancer latency and working
age range, only cancers in patients aged 25 years and above in 2005/
2004 could be attributable to occupation. In the present study, a
latency period of between 0 and 20 years has been assumed for all
the haematopoietic malignancies. Estimation has been carried out
for all leukaemias together, except for benzene where attributable
numbers have been calculated by applying the estimated AF to
estimated numbers of AML, acute promyelocytic leukaemia, acute
myelomonocytic leukaemia, and acute monocytic leukaemia and IR
where CLL has been excluded. Attributable fractions have been
calculated for the following: leukaemia and exposure to 1,3-
butadiene, benzene, EO, formaldehyde, IR and non-arsenical
insecticides; NHL and exposure to non-arsenical insecticides,
TCDD (dioxins), tetrachloroethylene, TCE, and work as a hair-
dresser and barber; and MM and exposure to non-arsenical
insecticides. Table 3 provides a summary of the attributable deaths
and registrations in GB for 2005 and 2004 and shows the separate
estimates for men and women, respectively.
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registrations (male and female) for each type of malignancy were
as follows. For leukaemia the AF was 0.74% (95% CI¼0.00–3.86%),
giving in total 23 (95% CI¼5–120) attributable deaths and 38
(95% CI¼8–198) registrations. For MM the AF was 0.30% (95%
CI¼0.00–0.64%), giving in total 6 (95% CI¼0–12) attributable
deaths and 10 (95% CI¼0–21) registrations. For NHL the AF was
1.74% (95% CI¼0.03–5.35%), giving in total 57 (95% CI¼1–176)
attributable deaths and 140 (95% CI¼3–430) registrations.
Exposures affecting leukaemia, MM and NHL
An estimated 1159288 men and 348966 women were assessed as
‘ever exposed’ to non-arsenical insecticides during the REP. The total
AF for leukaemia and exposure to non-arsenical insecticides was
0.38% (95% CI¼0.09–0.68%), with 12 (95% CI¼3–21) attributable
deaths and 19 (95% CI¼5–35) attributable registrations. For NHL,
the total AF from exposure to non-arsenical insecticides was 0.38%
(95% CI¼0.19–0.58%), with 13 (95% CI¼7–21) attributable deaths
and 33 (95% CI¼16–50) attributable registrations. For MM, the total
AF from exposure to non-arsenical insecticides was 0.30% (95%
CI¼0.00–0.64%), with 6 (95% CI¼0–12) attributable deaths and 10
(95% CI¼0–21) attributable registrations.
Exposures affecting ANLL
An estimated 342236 men and 704474 women were assessed as
‘ever exposed’ to benzene during the REP. For ANLL and exposure
to benzene, the total AF was 0.25% (95% CI¼0.00–4.65%), with
4 (95% CI¼0–78) attributable deaths and 7 (95% CI¼0–128)
registrations.
Exposures affecting leukaemia
An estimated 5468 men and 2817 women were assessed as ‘ever
exposed’ to 1,3-butadiene. For leukaemia and exposure to 1,3-
butadiene, the total AF was 0.01% (95% CI¼0.00–0.06%), with 0
(95% CI¼0–2) attributable deaths and 0 (95% CI¼0–3) registrations.
An estimated 5310 men and 4429 women were assessed as ‘ever
exposed’ to EO. For leukaemia and exposure to EO, the total AF
was 0.01% (95% CI¼0.00–0.21), with 0 (95% CI¼0–7)
attributable deaths and 1 (95% CI¼ 0–11) registrations.
An estimated 186617 men and 83078 women were assessed as
‘ever exposed’ to formaldehyde. For leukaemia and exposure to
formaldehyde, the total AF was 0.20% (95% CI¼0.05–0.48%),
with 6 (95% CI¼2–15) attributable deaths and 10 (95% CI¼
3–25) registrations.
Table 3 Lymphohaematopoietic malignancies: burden estimation results
Agent
Number
of men
ever
exposed
Number
of women
ever
exposed
Proportion
of men
ever
exposed
Proportion
of women
ever
exposed
AF
men
(95% CI)
AF
women
(95% CI)
Attributable
deaths
(men)
(95% CI)
Attributable
deaths
(women)
(95% CI)
Attributable
registrations
(men)
(95% CI)
Attributable
registrations
(women)
(95% CI)
Leukaemia
Benzene 342,236 704,474 0.0149 0.0305 0.0019
(0.0000–0.0033)
0.0034
(0.0000–0.0068)
2
(0–33)
2
(0–45)
3
(0–59)
3
(0–68)
1,3-Butadiene 5,468 2,817 0.0002 0.000 0.0001
(0.0000–0.0008)
0.0000
(0.0000–0.0004)
0
(0–2)
00
(0–3)
0
(0–1)
Ethylene oxide 5,310 4,429 0.0002 0.0002 0.0002
(0.0000–0.0019)
0.0000
(0.0000–0.0026)
0
(0–4)
0
(0–3)
1
(0–6)
0
(0–5)
Formaldehyde 186,617 83,078 0.0081 0.0036 0.0024
(0.0006–0.0060)
0.0012
(0.0004–0.0027)
5
(1–12)
1
(0–3)
8
(2–20)
2
(1–5)
Ionising radiation 149,974 33,770 0.0065 0.0015 0.0002 0.0001 0 0 1 0
Non-arsenical
insecticides
1,159,288 348,966 0.0504 0.0151 0.0050
(0.0012–0.0091)
0.0015
(0.0004–0.0027)
10
(2–18)
2
(0–3)
17
(4–30)
3
(1–5)
Totalsa 0.0088
(0.0020–0.0353)
0.0048
(0.0008–0.0447)
18
(4–71)
5
(1–49)
30
(7–118)
9
(1–80)
Multiple myeloma
Non-arsenical
insecticides
1,159,288 348,966 0.0504 0.0151 0.0045
(0.0000–0.0097)
0.0014
(0.0000–0.0029)
5
(0–10)
1
(0–2)
8
(0–18)
2
(0–3)
Non-Hodgkin’s lymphoma
Hairdressers and
barbers
45,726 404,672 0.0020 0.0175 0.0004
(0.0000–0.0014)
0.0035
(0.0000–0.0012)
1
(0–3)
4
(0–15)
2
(0–6)
12
(0–41)
Non-arsenical
insecticides
1,159,288 348,966 0.0504 0.0151 0.0056
(0.0027–0.0086)
0.0018
(0.0009–0.0027)
11
(5–17)
2
(1–3)
27
(13–41)
6
(3–9)
TCDD 838,863 272,873 0.0036 0.0118 0.013
(0.0000–0.059)
0.0040
(0.0000–0.0019)
25
(0–118)
5
(0–24)
61
(0–281)
14
(0–65)
Tetrachloro-
ethylene
249,421 123,004 0.0108 0.0053 0.0025
(0.0000–0.0135)
0.0016
(0.0000–0.0085)
5
(0–27)
2
(0–11)
12
(0–64)
5
(0–30)
Trichloroethylene 24,728 26,444 0.0011 0.0011 0.0003
(0.0000–0.0007)
0.0003
(0.0000–0.0007)
1
(0–1)
0
(0–1)
1
(0–3)
1
(0–2)
Totalsa 0.0021
(0.0000–0.0069)
0.0011
(0.0009–0.0029)
43
(0–138)
14
(1–37)
102
(0–328)
39
(3–101)
Abbreviations: AF¼attributable fraction; TCDD¼2,3,7,8-tetrachlorodibenzo-para-dioxin.
aTotals are the product sums and are not therefore equal to the sums of the separate
estimates of attributable fraction, deaths and registrations for each agent. The difference is especially notable where the constituent AFs are large.
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‘ever exposed’ to IR during the REP. For the total leukaemias
(excluding CLL) and exposure to IR, the total AF was 0.02%, with
no attributable deaths and only one registration.
Exposures affecting NHL
An estimated 838,863 men and 272,873 women were assessed as
‘ever exposed’ to TCDD during the REP. For NHL, the total AF
from exposure to TCDD was 0.86% (95% CI¼0.00–4.00%), with
31 (95% CI¼0–142) attributable deaths and 74 (95% CI¼0–346)
attributable registrations. Men involved in the iron and steel
industry had the largest number of attributable registrations and
deaths (19 and 8, respectively, for NHL).
An estimated 45,726 men and 404,672 women were assessed as
‘ever employed’ as a hairdresser or barber during the REP. For the
NHL and employment as a hairdresser, the total AF was 0.19%
(95% CI¼0.00–0.63%), with 5 (95% CI¼0–18) attributable
deaths and 14 (95% CI¼0–48) registrations.
An estimated 249,421 men and 123,004 women were assessed as
‘ever exposed’ to tetrachloroethylene during the REP. For NHL
and exposure to tetrachloroethylene, the total AF was 0.20%
(95% CI¼0.00–1.12%), with 7 (95% CI¼0–38) attributable
deaths and 17 (95% CI¼0–94) registrations. Individuals involved
in personal and household services, which includes dry cleaning,
had the largest number of attributable registrations and deaths,
for both men (9 and 4, respectively) and women (4 and 2,
respectively).
An estimated 24,728 men and 26,444 women were assessed as
‘ever exposed’ to TCE during the REP. For NHL and exposure
to TCE, the total AF was 0.03% (95% CI¼0.00–0.07), with
1 (95% CI¼0–2) death and 3 (95% CI¼0–6) registrations.
DISCUSSION
The results for leukaemia update those previously published (HSE,
2007). Because of the availability of more recent data, the overall
estimates have increased from 0.2% to 0.74% (0.3% to 0.88% for men,
and 0.05% to 0.48% for women). However, the revised overall
estimate is at the lower end of the range given by Steenland et al
(2003) of an AF estimate ranging from 0.8 to 2.0. It is also
significantly lower than the AF estimate of 10.9 reported by Nurminen
and Karjalainen (2001) for Finland; the AF estimate of 4.1 for workers
in France (Boffetta et al, 2010); and the global estimate of 3% reported
by Driscoll. It should be noted that in the Global Burden study the
risk estimates for leukaemia were 2.0 for low exposures and 4.0 for
high exposures, with countries such as the United Kingdom assumed
to have 90% of the exposed workforce at the ‘low level’ and 10% at the
high level of exposure (Driscoll et al, 2005). Exposure levels, which
could give risk estimates of this size, are unlikely to have existed in
Britain in the REP of concern in this study.
For NHL, the overall AF estimate was 1.74, with 57 deaths and 140
registrations. This is a third of the figure of 4.7 given by Nurminen and
Karjalainen (2001) for Finland, who also gave figures of 13.5% for men
and 3.1% for women, compared with 0.9% and 0.5% in this study.
Classification changes agreed in a recent re-evaluation of chemical
agents by IARC (Baan et al, 2009) mean that our estimates for all of
these malignancies are likely to be underestimated. Benzene was
classified as a probable carcinogen (2A) for chronic lymphocytic
leukaemia, MM and NHL; EO was classified as probable carcinogen for
NHL, MM and CLL; and work in the rubber industry was classified as a
definite carcinogen for lymphomas overall (Baan et al, 2009).
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